Nebivolol
Nebivolol is a pharmaceutical drug with 74 clinical trials. Currently 3 active trials ongoing. Historical success rate of 86.2%.
Success Metrics
Based on 50 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
7
Mid Stage
50
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.0%
50 of 61 finished
18.0%
11 ended early
3
trials recruiting
74
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
24 Hour Ambulatory Cardiac Oxygen Consumption
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
Clinical Trials (74)
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
24 Hour Ambulatory Cardiac Oxygen Consumption
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
Beta-blockade in Unruptured Intracranial Aneurysm
Determination of Drug Levels for Pharmacotherapy of Heart Failure
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
Effect of Different Antihypertensive Drugs on Central Blood Pressure
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure
To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide
A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm
Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke
The Effect of Nebivolol on Insulin Sensitivity
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 74